Savica R, Beghi E, Mazzaglia G, Innocenti F, Brignoli O, Cricelli C, Caputi A P, Musolino R, Spina E, Trifirò G
Department of Neuroscience, Psychiatry and Anesthesiology, University of Messina, Italy.
Eur J Neurol. 2007 Dec;14(12):1317-21. doi: 10.1111/j.1468-1331.2007.01970.x. Epub 2007 Sep 26.
To evaluate prevalence of use and prescribing patterns of antiepileptic drugs (AEDs) in Italian general practice. Primary care data were obtained from the Health Search Database, a longitudinal observational database implemented by the Italian College of General Practitioners (GPs). We selected 465 061 subjects registered by the end of 2005 in the lists of 320 GPs, homogeneously distributed throughout Italy. Prevalence of AED use was assessed in the entire sample and by drug type, age group, year and main geographic area (north, centre and south/islands). Overall, 24 383 subjects (5.2%) received at least one AED prescription in the study period. Prevalence of AED use (with 95% confidence interval) increased progressively from 7.1 (6.9-7.3) in 2000 to 11.8 (11.5-12.1) in 2005 for old AEDs and from 1.1 (1.0-1.2) to 12.2 (11.9-12.5) for new AEDs. Carbamazepine, phenobarbital and valproic acid were the most common AEDs until 2003, when gabapentin became first. There were no differences in prescribing patterns in the three main geographic areas. Newer AEDs were mostly used in patients aged 65 years and older. The more widespread use of newer AEDs was for mood disorders or pain. Older AED currently remain first line drugs for epileptic disorders. An increasing use of AEDs has been recently observed over a 6-year period in Italian general practice, mostly explained by newer compounds used for conditions other than epilepsy.
评估意大利全科医疗中抗癫痫药物(AEDs)的使用情况及处方模式。初级保健数据来自健康搜索数据库,这是一个由意大利全科医生学院(GPs)建立的纵向观察数据库。我们选取了2005年底在320名全科医生名单上登记的465061名受试者,他们在意大利各地分布均匀。在整个样本中以及按药物类型、年龄组、年份和主要地理区域(北部、中部和南部/岛屿)评估AEDs的使用情况。总体而言,在研究期间,24383名受试者(5.2%)接受了至少一张AED处方。旧型AEDs的使用患病率(95%置信区间)从2000年的7.1(6.9 - 7.3)逐渐上升至2005年的11.8(11.5 - 12.1),新型AEDs则从1.1(1.0 - 1.2)升至12.2(11.9 - 12.5)。直到2003年,卡马西平、苯巴比妥和丙戊酸一直是最常用的AEDs,之后加巴喷丁跃居首位。三个主要地理区域的处方模式没有差异。新型AEDs大多用于65岁及以上的患者。新型AEDs在情绪障碍或疼痛方面的使用更为广泛。目前,旧型AEDs仍是癫痫疾病的一线药物。最近在意大利全科医疗中观察到,AEDs的使用在6年期间呈上升趋势,这主要是由于新型化合物用于癫痫以外的病症。